Anhui Sunhere Pharmaceutical Excipients (300452.SZ) shareholder Shanghai Fosun Pharmaceutical plans to reduce its shareholding by no more than 3%.

Anhui Sunhere Pharmaceutical Excipients (300452.SZ) announced that its shareholder Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. (hereinafter referred to as "Shanghai Fosun Pharmaceutical") plans to reduce its holdings of the company's shares by a total of no more than 6.9787 million shares, or 3% of the total share capital of the company, through centralized bidding and block trading methods within 90 days after the announcement (from November 24, 2025, to February 21, 2026).